{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:22:16Z","timestamp":1778865736980,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010042","name":"Special Fund for Agro-scientific Research in the Public Interest","doi-asserted-by":"crossref","award":["201003060"],"award-info":[{"award-number":["201003060"]}],"id":[{"id":"10.13039\/501100010042","id-type":"DOI","asserted-by":"crossref"}]},{"name":"High Technology Research and Development of China","award":["2011AA10A211-5"],"award-info":[{"award-number":["2011AA10A211-5"]}]},{"name":"High Technology Research and Development of China","award":["2011AA10A212"],"award-info":[{"award-number":["2011AA10A212"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.03.090","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T04:35:36Z","timestamp":1428640536000},"page":"2449-2456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets"],"prefix":"10.1016","volume":"33","author":[{"given":"Huawei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.03.090_bib0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.virusres.2011.11.018","article-title":"Genetic variation of porcine circovirus type 2 (PCV2) and its relevance to vaccination, pathogenesis and diagnosis","volume":"164","author":"Trible","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0175","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tvjl.2010.01.018","article-title":"Recent advances in the epidemiology, diagnosis and control of diseases caused by porcine circovirus type 2","volume":"187","author":"Grau-Roma","year":"2011","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0180","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virusres.2011.10.005","article-title":"Porcine circovirus type 2 and its associated diseases in China","volume":"164","author":"Ge","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0185","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.vaccine.2007.12.019","article-title":"Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins","volume":"26","author":"Fort","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virusres.2011.10.013","article-title":"Porcine circovirus type 2 and its associated diseases in Korea","volume":"164","author":"Chae","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0300985812450726","article-title":"Current state of knowledge on porcine circovirus type 2-associated lesions","volume":"50","author":"Opriessnig","year":"2012","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virusres.2011.09.041","article-title":"Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2)","volume":"164","author":"Beach","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vetmic.2003.10.014","article-title":"Molecular biology of porcine circovirus: analyses of gene expression and viral replication","volume":"98","author":"Mankertz","year":"2004","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-animal-031412-103720","article-title":"Porcine circovirus type 2 (PCV2): pathogenesis and interaction with the immune system","volume":"1","author":"Meng","year":"2013","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0215","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jviromet.2014.07.021","article-title":"Secretory expression of porcine circovirus type 2 capsid protein in Pichia pastoris","volume":"207","author":"Silva","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0220","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1128\/JVI.00737-11","article-title":"The 2.3-Angstrom structure of porcine circovirus 2","volume":"85","author":"Khayat","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0225","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2012.04.022","article-title":"Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition","volume":"30","author":"Trible","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0230","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1089\/hum.2012.205","article-title":"Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine","volume":"24","author":"Grossardt","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0235","doi-asserted-by":"crossref","first-page":"e63384","DOI":"10.1371\/journal.pone.0063384","article-title":"Recombinant rabies viruses expressing GM-CSF or Flagellin are effective vaccines for both intramuscular and oral immunizations","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/1933719112459236","article-title":"Granulocyte-macrophage colony-stimulating factor enhances the humoral immune responses of mouse zona pellucida 3 vaccine strategy based on DNA and protein coadministration in BALB\/c mice","volume":"20","author":"Kadir","year":"2012","journal-title":"Reprod Sci"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0245","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.4161\/hv.21978","article-title":"Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine","volume":"8","author":"Hellerstein","year":"2014","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0250","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1016\/j.vaccine.2014.10.003","article-title":"Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits","volume":"32","author":"Zhang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0255","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.3390\/v6124839","article-title":"Virus-like particles of chimeric recombinant porcine circovirus type 2 as antigen vehicle carrying foreign epitopes","volume":"6","author":"Zhang","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0260","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.vaccine.2012.11.062","article-title":"Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-\u03b3 in mice","volume":"31","author":"Wang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00705-011-1130-9","article-title":"Genetic characterization and phylogenetic analysis of porcine circovirus type 2 (PCV2) in Serbia","volume":"157","author":"Savic","year":"2011","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0270","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11262-012-0789-7","article-title":"Genetic variation and phylogenetic analysis of porcine circovirus type 2 infections in central China","volume":"45","author":"Mu","year":"2012","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0275","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1099\/vir.0.039552-0","article-title":"Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA","volume":"93","author":"Shen","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0280","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.rvsc.2012.11.019","article-title":"Prevalence and genetic variation of porcine circovirus type 2 in Taiwan from 2001 to 2011","volume":"94","author":"Wang","year":"2013","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0285","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1016\/j.vaccine.2009.04.028","article-title":"One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model","volume":"27","author":"Fort","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0290","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1348-0421.2011.00311.x","article-title":"A candidate inactivated chimeric vaccine PCV1-2 constructed based on PCV1 and PCV2 isolates originating in China and its evaluation in conventional pigs in regard to protective efficacy against PCV2 infection","volume":"55","author":"Xujie","year":"2011","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0295","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.vaccine.2008.11.105","article-title":"Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV\u2013PCV2\u2013SIV clinical infection model 2\u20133-months post vaccination","volume":"27","author":"Opriessnig","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0300","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tvjl.2012.06.031","article-title":"Commercial porcine circovirus type 2 vaccines: efficacy and clinical application","volume":"194","author":"Chae","year":"2012","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0305","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1016\/j.vaccine.2014.06.004","article-title":"Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2","volume":"32","author":"Opriessnig","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0310","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.vaccine.2012.11.030","article-title":"A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a\/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection","volume":"31","author":"Opriessnig","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0315","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2008.04.036","article-title":"Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens","volume":"364","author":"Perrie","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0320","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.vetimm.2010.03.025","article-title":"Immune responses and vaccine-induced immunity against porcine circovirus type 2","volume":"136","author":"Kekarainen","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0325","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0264-410X(98)00346-6","article-title":"A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin\/neuraminidase and IL-2 or GM-CSF, I. Vaccine characterization and efficacy studies in mice","volume":"17","author":"Babai","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.090_bib0330","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0264-410X(98)00347-8","article-title":"A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin\/neuraminidase and IL-2 or GM-CSF, II. Induction of TH1 and TH2 responses in mice","volume":"17","author":"Babai","year":"1999","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500420X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1500420X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T03:13:23Z","timestamp":1589512403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1500420X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":33,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X1500420X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.090","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}